The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Health Care Select Sector SPDR® ETF XLV
Morningstar’s Analysis XLV
Will XLV outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 55.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.15 | 4.2 Bil | Healthcare |
UnitedHealth Group Inc | 8.81 | 3.3 Bil | Healthcare |
Johnson & Johnson | 6.82 | 2.6 Bil | Healthcare |
Merck & Co Inc | 6.39 | 2.4 Bil | Healthcare |
AbbVie Inc | 5.70 | 2.2 Bil | Healthcare |
Thermo Fisher Scientific Inc | 4.26 | 1.6 Bil | Healthcare |
Abbott Laboratories | 3.58 | 1.4 Bil | Healthcare |
Danaher Corp | 3.12 | 1.2 Bil | Healthcare |
Amgen Inc | 2.78 | 1.0 Bil | Healthcare |
Pfizer Inc | 2.75 | 1.0 Bil | Healthcare |